Conference item icon

Conference item

Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
Expand authors...
Volume:
132
Issue:
4
Pages:
A157-A157
Host title:
GASTROENTEROLOGY
Publication date:
2007-04-01
ISSN:
0016-5085
Source identifiers:
66738
Pubs id:
pubs:66738
UUID:
uuid:37f13f4e-8a9b-4ad1-8f4d-cc5bad788a48
Local pid:
pubs:66738
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP